Clarius Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Clarius Group's VRTX Position: Q4 2025 in Review
Clarius Group reduced its Vertex Pharmaceuticals (VRTX) stake by 0.41% in Q4 2025, selling an estimated $1.72K and leaving 983 shares worth $446K. The position accounts for 0.03% of the portfolio, ranked #224.
Clarius Group first reported a position in VRTX in Q1 2019 and has held it in 27 quarters since. The position peaked at $881K in Q1 2025. 1,681 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.
- Clarius Group held 983 shares of Vertex Pharmaceuticals worth $446K as of Q4 2025.
- Clarius Group sold 4 Vertex Pharmaceuticals shares in Q4 2025, an estimated $1.72K.
- Vertex Pharmaceuticals made up 0.03% of Clarius Group's portfolio in Q4 2025, its #224 holding.
- Clarius Group first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 27 quarters since.
- Clarius Group's Vertex Pharmaceuticals position peaked at $881K in Q1 2025.
- 1,681 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.
Based on Clarius Group's 13F filing for Q4 2025, filed 14 Jan 2026.